HORIZON-JU-EDCTP3-2026-Dr Pascoal Mocumbi Prize

Résumé

This is the Dr Pascoal Mocumbi Prize, a recognition award under the Horizon Europe EDCTP3 joint undertaking. The call has a deadline of 2 September 2026. No further details regarding budget, eligibility criteria, or specific requirements are provided in the available information.

This is a recognition prize call under the EDCTP3 (European & Developing Countries Clinical Trials Partnership) program, which focuses on clinical trials and health research in infectious diseases affecting developing countries. Acme Corporation, a semiconductor and AI company, has no alignment with clinical trials, pharmaceutical development, or public health research, making this call fundamentally incompatible with the client's domain and strategic priorities.

Scores détaillés

Pas d'analyse approfondie — ce score ≤ 6,0 n'a pas déclenché l'analyse détaillée. Voir l'analyse d'adéquation ci-dessus.

Description

HORIZON Recognition Prize Call: HORIZON-JU-EDCTP3-2026-DRPASCOALMOCUMBIPRIZE Programme period: 2021 - 2027